Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Liver Diseases

Free Subscription 14.10.2019 1 AJR Am J Roentgenol 1 Anticancer Res 5 Biochem Biophys Res Commun 2 Dig Dis Sci 1 Gastroenterology 5 Hepatology 1 Int J Cancer 1 J Gastroenterol Hepatol 1 J Hepatol 1 J Pediatr 1 Oncogene 2 Radiology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. SUREKA B, Yadav T, Khera PS
   Differential Diagnoses of Calcified Liver Lesions.
   AJR Am J Roentgenol. 2019;212:W20.
   PubMed     Text format    
   
   

   
   Anticancer Res

2. HUNG YH, Lin YC, Lin YT, Shih GW, et al
   Therapeutic Efficacy and Radiobiological Effects of Boric Acid-mediated BNCT in a VX2 Multifocal Liver Tumor-bearing Rabbit Model.
   Anticancer Res. 2019;39:5495-5504.
   PubMed     Text format     Abstract available
   
   

   
   Biochem Biophys Res Commun

3. FURUKAWA S, Yamaguchi M, Ooka A, Kikuchi H, et al
   Differentiation-inducing factor-1 prevents hepatic stellate cell activation through inhibiting GSK3beta inactivation.
   Biochem Biophys Res Commun. 2019 Sep 30. pii: S0006-291X(19)31855.
   PubMed     Text format     Abstract available
   
   
4. LI S, Lin Z, Zheng W, Zheng L, et al
   IL-17A inhibits autophagic activity of HCC cells by inhibiting the degradation of Bcl2.
   Biochem Biophys Res Commun. 2019;509:194-200.
   PubMed     Text format     Abstract available
   
   
5. SUN J, Li P, Yang J
   Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS.
   Biochem Biophys Res Commun. 2019;509:8-15.
   PubMed     Text format     Abstract available
   
   
6. INAMURA K, Komizu Y, Yamakuchi M, Ishida S, et al
   Inhibitory effect of hybrid liposomes on the growth of liver cancer stem cells.
   Biochem Biophys Res Commun. 2018 Dec 21. pii: S0006-291X(18)32771.
   PubMed     Text format     Abstract available
   
   
7. TSUMA Y, Mori J, Ota T, Kawabe Y, et al
   Erythropoietin and long-acting erythropoiesis stimulating agent ameliorate non-alcoholic fatty liver disease by increasing lipolysis and decreasing lipogenesis via EPOR/STAT pathway.
   Biochem Biophys Res Commun. 2019;509:306-313.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis Sci

8. ZOU B, Yeo YH, Jeong D, Park H, et al
   A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.
   Dig Dis Sci. 2019 Oct 9. pii: 10.1007/s10620-019-05869.
   PubMed     Text format     Abstract available
   
   
9. WEN X, Ling S, Wu W, Shan Q, et al
   Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma.
   Dig Dis Sci. 2019 Oct 5. pii: 10.1007/s10620-019-05844.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterology

10. LE BERRE C, Sandborn WJ, Aridhi S, Devignes MD, et al
    Application of Artificial Intelligence to Gastroenterology and Hepatology.
    Gastroenterology. 2019 Oct 5. pii: S0016-5085(19)41412.
    PubMed     Text format     Abstract available
    
    

    
    Hepatology

11. HUANG R, Wang J, Zhang Z, Yan X, et al
    Letter to the Editor: Impact of non-alcoholic steatohepatitis on liver-related outcomes in chronic hepatitis B.
    Hepatology. 2019 Oct 6. doi: 10.1002/hep.30981.
    PubMed     Text format     Abstract available
    
    
12. FELLI E, Saviano A, Tripon S, Baumert TF, et al
    Letter to the Editor: Abdominal Surgery in Idiopathic Noncirrhotic Portal Hypertension: Is Preemptive TIPS Reducing Postoperative Complications?
    Hepatology. 2019 Oct 9. doi: 10.1002/hep.30985.
    PubMed     Text format     Abstract available
    
    
13. LIU F, Goh GB, Tiniakos D, Wee A, et al
    qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis.
    Hepatology. 2019 Oct 10. doi: 10.1002/hep.30986.
    PubMed     Text format     Abstract available
    
    
14. JAHN D, Geier A
    Bile acids in NASH: pathophysiological driving force or innocent bystanders?
    Hepatology. 2017 Sep 19. doi: 10.1002/hep.29543.
    PubMed     Text format    
    
    
15. JARAMILLO-CALLE DA, Castano Quintero O, Marin JI, Cock-Rada AM, et al
    Is liver transplantation for intractable attacks of porphyria a viable treatment in a developing country?
    Hepatology. 2017 Nov 15. doi: 10.1002/hep.29650.
    PubMed     Text format    
    
    

    
    Int J Cancer

16. PETRICK JL, Florio AA, Znaor A, Ruggieri D, et al
    International trends in hepatocellular carcinoma incidence, 1978-2012.
    Int J Cancer. 2019 Oct 9. doi: 10.1002/ijc.32723.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol Hepatol

17. TOBARI M, Hashimoto E, Taniai M, Kodama K, et al
    The characteristics and risk factors of hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis.
    J Gastroenterol Hepatol. 2019 Oct 9. doi: 10.1111/jgh.14867.
    PubMed     Text format     Abstract available
    
    

    
    J Hepatol

18. BRIL F, Barb D, Lomonaco R, Lai J, et al
    Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis.
    J Hepatol. 2019 Oct 4. pii: S0168-8278(19)30584.
    PubMed     Text format     Abstract available
    
    

    
    J Pediatr

19. BLACK DD
    Impact of Bariatric Surgery on Adipose Tissue and Liver Inflammation in Adolescents with Nonalcoholic Steatohepatitis.
    J Pediatr. 2019 Oct 3. pii: S0022-3476(19)31126.
    PubMed     Text format    
    
    

    
    Oncogene

20. LI B, Chen Y, Wang F, Guo J, et al
    Bmi1 drives hepatocarcinogenesis by repressing the TGFbeta2/SMAD signalling axis.
    Oncogene. 2019 Oct 7. pii: 10.1038/s41388-019-1043.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

21. MOTOSUGI U
    Improving Postsurgical Outcome in Patients with HCC by Using a Hepatobiliary Contrast Agent.
    Radiology. 2019 Oct 8:191990. doi: 10.1148/radiol.2019191990.
    PubMed     Text format    
    
    
22. KIM DK, An C, Chung YE, Choi JY, et al
    Hepatobiliary versus Extracellular MRI Contrast Agents in Hepatocellular Carcinoma Detection: Hepatobiliary Phase Features in Relation to Disease-free Survival.
    Radiology. 2019 Oct 8:190414. doi: 10.1148/radiol.2019190414.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: